Christina Vander Pluym
Advanced Heart Failure and Transplant Cardiology · Boston, MANPI 1366722266
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Astrazeneca AB at 33.0% of the total. Reporting peaked in 2023 at $35,948 and has fallen 99.2% since, to $305 in 2025.
Across 56 payments — averaging $974.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca AB$18K
- Merck$18K
- Abiomed$12K
- Abbott$3K
- Medtronic$2K
- Berlin Heart Inc$1K
Across 24 payments — averaging $16,535 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Berlin Heart Inc$181K
- Roche Diagnostics Corporation$159K
- E.r. Squibb & Sons, L.L.C.$55K
- Janssen Research & Development, LLC$2K
What the payments were for
- Consulting fees$28,20852%
- Speaking & faculty fees$12,00022%
- Travel & lodging$12,86524%
- Food & beverage$1,4783%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca AB | 7 | $18,017 |
| Merck | 14 | $17,876 |
| Abiomed | 8 | $12,376 |
| Abbott | 17 | $3,206 |
| Medtronic(2 entities) | 7 | $2,062 |
| Berlin Heart Inc | 3 | $1,014 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$17,884
- VERQUVO$17,381
- Impella$12,136
- HeartMate 3 Left Ventricular Dev$2,728
- HeartWare HVAD$1,750
- CentriMag$150
How this compares
$54,551 in reported general payments places this provider in the 85th percentile of 35 advanced heart failure and transplant cardiology providers in Massachusetts.
See all advanced heart failure and transplant cardiology providers in Massachusetts →
Other advanced heart failure and transplant cardiology in Boston
- Pablo Quintero PinzonBoston$137K
- Daniel ZlotoffBoston$96K
- Monica AhluwaliaBoston$39K
- Stephanie MooreBoston$30K
- David DenofrioBoston$18K
- Robb KociolBoston$12K
- Marwa SabeBoston$12K
- Edward GrandinBoston$8K
- Kemar BrownBoston$7K
- Kevin DalyBoston$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.